Market access and reimbursement in Canada – changes at CADTH

Pharma Market Access Insights - from Mtech Access

What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa).
We take a look at the market access, health policy, and health technology assessment in Canada. Clare Foy and Don Husereau explore:

• The market access landscape in Canada
• Upcoming changes at CADTH
• What Canadian payers expect from your value proposition
• Opportunities and challenges when launching new medicines/medical devices/diagnostics in Canada
• How Canada compares to the USA/key European launch markets
• What this means for your global market access strategy

This episode was first broadcast as a live webinar in March 2024. Learn more at https://mtechaccess.co.uk/market-access-canada-changes-cadth/
Learn more about the Canadian healthcare market and launching new pharma and medtech innovations at: https://mtechaccess.co.uk/launching-healthcare-products-in-canada/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Chapters

1. Welcome and introductions (00:00:00)

2. Challenges of achieving access for a pharma or medtech product in Canada (00:02:17)

3. The role of CADTH in HTA recommendations in Canada (00:04:18)

4. The time-limited drug reimbursement recommendation (00:05:58)

5. How pharmaceutical pricing works in Canada overall (00:10:38)

6. Introduction of the Canadian Drug Agency (CDA) (00:14:16)

7. Impact of European Joint Clinical Assessment (JCA) in Canada (00:24:28)

8. CDA and the regulatory landscape in Canada (00:26:55)

9. CADTH for Medtech (00:30:08)

10. Rare disease strategy in Canada (00:35:42)

11. Schemes for registry data and real-world evidence (00:39:22)

12. Key lessons and final thoughts (00:43:10)